Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

June 3, 2021
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

[PDF-163.78 KB]

English

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Updated June 3, 2021

All clinical specimens may contain potentially infectious materials. Precautions should be taken when handling specimens suspected or confirmed to be positive for SARS-CoV-2, the virus that causes COVID-19. Timely communication between clinical and laboratory staff is essential to minimize the potential risk of handling specimens from patients with possible SARS-CoV-2 infection. These specimens should be labeled accordingly, and the receiving laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling SARS-CoV-2 specimens are provided below. For additional information on handling SARS-CoV-2 specimens, refer to the Laboratory Frequently Asked Questions.
Content Notes:

General Guidance -- Routine Diagnostic Testing -- Anatomic Pathology -- Decentralized and Point-of-Care Testing -- Environmental Testing -- Specimen Packing and Shipping -- Procedures with a High Likelihood of Generating Droplets or Aerosols -- Virus Isolation -- Decontamination -- Laboratory Waste Management -- Additional Resources.
Subjects:

[+]

Clinical Laboratory Techniques Communicable Diseases, Emerging Containment Of Biohazards Coronavirus Infections/diagnosis COVID-19 Respiratory Tract Infections/diagnosis Safety Specimen Handling
Document Type:

Webpage
Genre:

Guidance
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:aa72f47ac469813e4ab90b26501681e1fb7de9e170955051578530fdf7812ac1
Download URL:

https://stacks.cdc.gov/view/cdc/106807/cdc_106807_DS1.pdf
File Type:

lab-biosafety-guidelines.html

htm

More +